These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 37418235)

  • 1. A multitier virtual screening study of phytoconstituents as Myeloid Cell Leukemias 1 inhibitors.
    Liu W; Khalid M; Wahab S; Faizan Siddiqui M; Hasan Khan S; Sadiq M; Khatoon Z
    J Biomol Struct Dyn; 2024 Jul; 42(10):5219-5228. PubMed ID: 37418235
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unraveling the molecular mechanism of benzothiophene and benzofuran scaffold-merged compounds binding to anti-apoptotic Myeloid cell leukemia 1.
    Marimuthu P; Singaravelu K
    J Biomol Struct Dyn; 2019 May; 37(8):1992-2003. PubMed ID: 29745292
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Alshehri SA; Wahab S; Almoyad MAA
    J Biomol Struct Dyn; 2024 Nov; 42(18):9463-9474. PubMed ID: 37643015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of Hot Spots at Myeloid Cell Leukemia-1-Inhibitor Interface Using Energy Estimation and Alanine Scanning Mutagenesis.
    Marimuthu P; Singaravelu K
    Biochemistry; 2018 Feb; 57(7):1249-1261. PubMed ID: 29345906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computer-aided anti-cancer drug discovery of EGFR protein based on virtual screening of drug bank, ADMET, docking, DFT and molecular dynamic simulation studies.
    Roney M; Dubey A; Hassan Nasir M; Tufail A; Tajuddin SN; Mohd Aluwi MFF; Huq AM
    J Biomol Struct Dyn; 2024 Nov; 42(18):9662-9677. PubMed ID: 37676262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phytoconstituents and Medicinal Plants for Anticancer Drug Discovery: Computational Identification of Potent Inhibitors of PIM1 Kinase.
    Anjum F; Mohammad T; Almalki AA; Akhtar O; Abdullaev B; Hassan MI
    OMICS; 2021 Sep; 25(9):580-590. PubMed ID: 34448628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive insights into plant-based compounds as fibroblast growth factor receptor 1 inhibitors: a combined molecular docking and dynamics simulation study.
    Almoyad MAA; Wahab S; Ansari MN; Ahmad W; Hani U; Chandra S
    J Biomol Struct Dyn; 2024 Apr; ():1-10. PubMed ID: 38669200
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovering potential inhibitors of Raf proto-oncogene serine/threonine kinase 1: a virtual screening approach towards anticancer drug development.
    Khan A; Bealy MA; Alharbi B; Khan S; Alharethi SH; Al-Soud WA; Mohammad T; Hassan MI; Alshammari N; Ahmed Al-Keridis L
    J Biomol Struct Dyn; 2024; 42(4):1846-1857. PubMed ID: 37104027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of molecular dynamics-based pharmacophore and machine learning approaches to identify novel Mcl1 inhibitors through drug repurposing and mechanics research.
    Wang H; Qi Z; Lian W; Ma L; Wang S; Liu H; Jin Y; Yang H; Wang J; Cheng M
    Phys Chem Chem Phys; 2024 Jun; 26(22):16107-16124. PubMed ID: 38780456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining empirical knowledge, in silico molecular docking and ADMET profiling to identify therapeutic phytochemicals from Brucea antidysentrica for acute myeloid leukemia.
    Bultum LE; Tolossa GB; Lee D
    PLoS One; 2022; 17(7):e0270050. PubMed ID: 35895695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico approaches to identify novel myeloid cell leukemia-1 (Mcl-1) inhibitors for treatment of cancer.
    Ren JX; Li CP; Zhou XL; Cao XS; Xie Y
    J Biomol Struct Dyn; 2018 Jul; 36(9):2424-2435. PubMed ID: 28714799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-guided identification of potent inhibitors of ROS1 kinase for therapeutic development against non-small cell lung cancer.
    Khan MS; Altwaijry N; Al-Bagmi MS; Alafaleq NO; Alokail MS; Shahwan M; Shamsi A
    J Biomol Struct Dyn; 2024 May; 42(8):3837-3847. PubMed ID: 37254309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based identification of potential inhibitors of ribosomal protein S6 kinase 1, targeting cancer therapy: a combined docking and molecular dynamics simulations approach.
    Alam A; Khan MS; Mathur Y; Sulaimani MN; Farooqui N; Ahmad SF; Nadeem A; Yadav DK; Mohammad T
    J Biomol Struct Dyn; 2024 Jul; 42(11):5758-5769. PubMed ID: 37365756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel
    Elasbali AM; Al-Soud WA; Elfaki EM; Alanazi HH; Alharbi B; Alharethi SH; Anwer K; Mohammad T; Hassan MI
    J Biomol Struct Dyn; 2024 Jul; 42(11):5982-5994. PubMed ID: 37403288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of high-affinity pyridoxal kinase inhibitors targeting cancer therapy: an integrated docking and molecular dynamics simulation approach.
    Banerjee P; Chandra A; Mohammad T; Singh N; Hassan MI; Qamar I
    J Biomol Struct Dyn; 2024 Oct; 42(16):8523-8540. PubMed ID: 37578056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of promising B lymphocyte kinase inhibitors using structure-guided virtual screening.
    Yang S; Wahab S; Almoyad MAA; Chen Y; Kalam N; Khalid M
    J Biomol Struct Dyn; 2024 Aug; 42(13):7054-7064. PubMed ID: 37688373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational investigation of imidazo[2,1-b]oxazole derivatives as potential mutant BRAF kinase inhibitors: 3D-QSAR, molecular docking, molecular dynamics simulation, and ADMETox studies.
    Boutalaka M; El Bahi S; Alaqarbeh M; El Alaouy MA; Koubi Y; Khatabi KE; Maghat H; Bouachrine M; Lakhlifi T
    J Biomol Struct Dyn; 2024 Jul; 42(10):5268-5287. PubMed ID: 37424193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential inhibitors of tropomyosin receptor kinase B targeting CNS-related disorders and cancers.
    Hakami MA; Alotaibi BS; Hazazi A; Shafie A; Alsaiari AA; Ashour AA; Anjum F
    J Biomol Struct Dyn; 2024 Apr; 42(6):2965-2975. PubMed ID: 37184150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An integrated docking and molecular dynamics simulation approach to discover potential inhibitors of activin receptor-like kinase 1.
    Jairajpuri DS; Mohammad T; Hussain A; Amir S; Fatima U; AlAjmi MF; Yadav DK; Hassan MI
    J Mol Recognit; 2024 Mar; 37(2):e3069. PubMed ID: 38053481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in silico molecular docking and simulation study to identify potential anticancer phytochemicals targeting the RAS signaling pathway.
    Azmal M; Paul JK; Prima FS; Talukder OF; Ghosh A
    PLoS One; 2024; 19(9):e0310637. PubMed ID: 39298437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.